The joint conference is an opportunity for molecular imaging & nuclear medicine professionals:

  1. To update the knowledge on the recent developments in this specialty.
  2. To be aware of new techniques and applications in the diagnosis and therapy using radiopharmaceuticals.
  3. To refresh knowledge in quality control, quality assurance, and radiation safety.
  4. To develop contacts and establish collaboration in the clinical, academic, and research areas.


We are inviting 10 international and regional experts to present their experience. Nine clinical sessions are planned where 3-4 lectures will be delivered. The first session will be dedicated to welcoming the delegates and inauguration. Two sessions each for PET/CT, General Nuclear Medicine, Cardiology, and Theragnostic are scheduled. In addition to FDG PET/CT, conventional nuclear medicine, I-131 therapy, and SPECT/CT, the lectures/presentations by the experts will also cover the PEM, non-FDG PET/CT, PET/MRI, imaging in cardiac amyloidosis, AI, new therapy tracers and conventional Nuclear Medicine in endocrine, renal, bone and GI disorders will also be covered by experts.

There will be four parallel sessions on techniques, radiation safety, image processing, and reconstruction of hybrid imaging primarily for the scientists and technical staff working in nuclear medicine.